P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 28 March 2020 | 4:15 pm

Novartis new analysis further shows durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials shows inclisiran reduced low-density lipoprotein-cholesterol (LDL-C) by 51% at 17 more ...

Published 28 March 2020 | 2:24 pm

Farxiga reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial

New data showed consistent effect of Farxiga in patients with heart failure with reduced ejection fraction, regardless of background therapy more ...

Published 28 March 2020 | 11:50 am

Resolutions from the Annual General Meeting of Novo Nordisk A/S

General Meeting (AGM). To comply with all instructions and precautions taken by the Danish authorities in response to the coronavirus pandemic, shareholders were requested more ...

Published 28 March 2020 | 12:50 am


5 MINUTES FDA grants emergency use authorization for fastest available molecular point-of-care test for novel coronavirus. more ...

Published 27 March 2020 | 8:29 pm

Antibiotic resistance: the hidden threat lurking behind Covid-19

Written by Julie L. Gerberding and originally published by STAT News more ...

Published 27 March 2020 | 3:42 pm

Pfizer Completes $1.25 Billion Sustainability Bond for Social and Environmental Impact

First in the industry sustainability bond provides opportunities to invest in projects supporting environmental sustainability and health of vulnerable populations Supports United more ...

Published 27 March 2020 | 3:03 pm

Visualizing molecular glues

Molecular glues are a new type of medicine inspired by nature's matchmakers. more ...

Published 27 March 2020 | 2:56 pm

Novartis Cosentyx® gains positive CHMP opinion for new indication in the axial spondyloarthritis spectrum

EMA CHMP positive opinion in non-radiographic axial spondyloarthritis (nr-axSpA) paves way for fourth indication in Europe, and is based on Phase III PREVENT data 1 more ...

Published 27 March 2020 | 2:28 pm

COVID-19: Playing our part in the global response

These are challenging times. The surge of cases of COVID-19 is having a profound impact on people around the world, putting pressure on our health systems and disrupting more ...

Published 27 March 2020 | 2:14 pm

AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal muscular atrophy (SMA)

(onasemnogene abeparvovec), a one-time administered gene therapy, has been recommended for European Commission (EC) conditional approval for patients with spinal more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019

61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019